Noroclav Intramammary Suspension for Lactating Cows
Noroclav Intramammary Suspension for Lactating Cows
Authorised
- Amoxicillin trihydrate
- Potassium clavulanate
- Prednisolone
Product identification
Medicine name:
Noroclav Intramammary Suspension for Lactating Cows
Active substance:
- Amoxicillin trihydrate
- Potassium clavulanate
- Prednisolone
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Amoxicillin trihydrate229.60/milligram(s)1.00Applicator
-
Potassium clavulanate59.60/milligram(s)1.00Applicator
-
Prednisolone10.00/milligram(s)1.00Applicator
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (lactating cow)
-
Meat and offal7day
-
Milk84hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RV01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- (ID1) 9 gram(s): Box (cardboard) with 3 Applicator (low-density polyethylene) each with 3 gram(s)
- (ID2) 36 gram(s): Box (cardboard) with 12 Applicator (low-density polyethylene) each with 3 gram(s)
- (ID3) 72 gram(s): Box (cardboard) with 24 Applicator (low-density polyethylene) each with 3 gram(s)
- (ID4) 360 gram(s): Bucket with 120 Applicator (low-density polyethylene) each with 3 gram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories (Ireland) Limited
- Norbrook Laboratories Limited
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402467.00.00
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0328/001
Concerned member states:
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet